BALDWIN BROTHERS LLC/MA - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 2 filers reported holding PLURISTEM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$2,000
-33.3%
1,5420.0%0.00%
Q1 2022$3,000
+50.0%
1,542
+14.7%
0.00%
Q4 2021$2,000
-50.0%
1,3440.0%0.00%
Q3 2021$4,000
+33.3%
1,344
+81.6%
0.00%
Q2 2021$3,000
-25.0%
7400.0%0.00%
Q1 2021$4,000
-20.0%
7400.0%0.00%
-100.0%
Q4 2020$5,0007400.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 192,049$705,0000.29%
Values First Advisors, Inc. 45,405$166,6370.20%
ARK Investment Management 660,150$2,423,0000.06%
ALGERT GLOBAL LLC 20,200$74,0000.03%
Nikko Asset Management Americas, Inc. 408,724$1,500,0000.01%
Savior LLC 3,393$12,0000.01%
ETF MANAGERS GROUP, LLC 64,853$206,0000.01%
LEVIN CAPITAL STRATEGIES, L.P. 10,000$37,0000.01%
Psagot Value Holdings Ltd. 17,685$65,0000.00%
Certified Advisory Corp 500$2,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders